| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373218A1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373206A1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373204A2 Heterocyclic compounds |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1373182A1 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |
| 01/02/2004 | EP1372730A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 01/02/2004 | EP1372720A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 01/02/2004 | EP1372714A2 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids |
| 01/02/2004 | EP1372706A2 A novel proteosome-liposaccharide vaccine adjuvant |
| 01/02/2004 | EP1372704A1 Monocyte-specific particulate delivery vehicle |
| 01/02/2004 | EP1372701A2 Methods of therapy for hiv infection |
| 01/02/2004 | EP1372700A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372691A2 Mucin peptide with immunoenhancing properties |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372676A1 Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection |
| 01/02/2004 | EP1372668A2 Method of attenuating reactions to skin irritants |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372651A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372607A1 Adjuvant emulsion and method of using said emulsion |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/02/2004 | EP0663008B1 Improvements in or relating to immune response modification |
| 01/01/2004 | US20040002537 Multiple sclerosis; central nervous system disorders; side effect reduction |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002496 Compositions useful as inhibitors of protein kinases |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 01/01/2004 | US20040001860 Dietary supplements for enhancing the immune system |
| 01/01/2004 | US20040001856 Extract of lentinus lepideus and composition comprising the same having immune enhancing activity |
| 01/01/2004 | US20040001852 Deactivation antigen protein; anticancer agents; Aids therapy |
| 01/01/2004 | US20040001828 Treatment methods using anti-CD22 antibodies |
| 01/01/2004 | US20040001803 Effectors of innate immunity determination |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2004001022A1 Probiotic propionibacterium jensenii 702 |
| 12/31/2003 | WO2004001007A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 12/31/2003 | WO2004000831A1 Indole derivatives useful as histamine h3 antagonists |
| 12/31/2003 | WO2004000825A1 Novel compounds |
| 12/31/2003 | WO2004000820A2 Certain aromatic monocycles as kinase modulators |
| 12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000360A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2004000271A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 12/31/2003 | WO2004000219A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/31/2003 | WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/31/2003 | WO2003072036A3 Treatment methods using anti-cd22 antibodies |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003066095A3 MODULATING TOLERANCE BY MODULATING FcϜRIIB RECEPTOR SIGNALLING |
| 12/31/2003 | WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | WO2003055916A3 Adiponectin fragments and conjugates |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003038440A3 Chemokine binding molecules |
| 12/31/2003 | WO2003035004A9 Immunotherapy for reversing immune suppression |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2003006492A3 Biologically active peptides |
| 12/31/2003 | WO2002074333A3 Mycobacterial extracts used for treating allergy |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | WO2002047708A3 Selective cox-2 inhibition from edible plant extracts |
| 12/31/2003 | WO2002042444A3 Fungal gene cluster associated with pathogenesis |
| 12/31/2003 | WO2002042325A3 Cyp1b1 nucleic acids and methods of use |